(GRW) TCW Compounders - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: (N/A)

Tech, Healthcare, Consumer, Industrial, Financial

Description: GRW TCW Compounders

The TCW Compounders ETF (GRW) is a large-cap growth ETF listed on the NYSE ARCA, originating from the USA. As a growth-oriented investment vehicle, it is likely to focus on companies with high growth potential, strong earnings momentum, and competitive advantages.

To evaluate the ETFs performance, key metrics such as expense ratio, tracking error, and holdings diversification should be considered. A lower expense ratio and tracking error would indicate a more efficient investment product. Additionally, analyzing the ETFs sector allocation, market capitalization distribution, and top holdings can provide insights into its growth prospects and potential risks.

The ETFs performance is likely influenced by key economic drivers such as GDP growth, interest rates, and inflation. A strong GDP growth environment, characterized by low unemployment and rising consumer spending, tends to favor growth stocks. Conversely, rising interest rates and inflation can negatively impact growth stocks, particularly those with high valuations.

To assess the ETFs risk profile, metrics such as beta, standard deviation, and Value-at-Risk (VaR) can be employed. A beta of 0.95, as reported, indicates that the ETF is slightly less volatile than the broader market. However, a more comprehensive risk analysis would require examining the ETFs exposure to various risk factors, such as market risk, sector risk, and style risk.

When evaluating the ETFs potential for future growth, it is essential to examine its underlying holdings and their respective growth prospects. This includes analyzing metrics such as revenue growth, earnings per share (EPS) growth, and return on equity (ROE). A portfolio with a strong growth profile, combined with a reasonable valuation, is more likely to deliver sustained long-term performance.

GRW ETF Overview

Market Cap in USD 121m
Category Large Growth
IPO / Inception 2016-01-29

GRW ETF Ratings

Growth Rating 35.5%
Fundamental -
Dividend Rating 55.0%
Return 12m vs S&P 500 -17.1%
Analyst Rating -

GRW Dividends

Dividend Yield 12m 11.18%
Yield on Cost 5y 12.82%
Annual Growth 5y -100.00%
Payout Consistency 100.0%
Payout Ratio %

GRW Growth Ratios

Growth Correlation 3m -75.6%
Growth Correlation 12m -6.1%
Growth Correlation 5y 54.5%
CAGR 5y 9.55%
CAGR/Max DD 3y 0.64
CAGR/Mean DD 3y 4.26
Sharpe Ratio 12m 0.86
Alpha -15.13
Beta 0.717
Volatility 12.65%
Current Volume 1.9k
Average Volume 20d 12.4k
Stop Loss 31.8 (-3.2%)
Signal -0.43

What is the price of GRW shares?

As of September 16, 2025, the stock is trading at USD 32.86 with a total of 1,915 shares traded.
Over the past week, the price has changed by -0.33%, over one month by +1.73%, over three months by -3.28% and over the past year by -1.46%.

Is TCW Compounders a good stock to buy?

Partly, yes. Based on ValueRay´s Analyses, TCW Compounders (NYSE ARCA:GRW) is currently (September 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.53 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GRW is around 28.75 USD . This means that GRW is currently overvalued and has a potential downside of -12.51%.

Is GRW a buy, sell or hold?

TCW Compounders has no consensus analysts rating.

What are the forecasts/targets for the GRW price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 32.1 -2.3%

Last update: 2025-09-05 04:45

GRW Fundamental Data Overview

Market Cap USD = 121.3m (121.3m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.93
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 121.3m USD (121.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 121.3m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 121.3m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(121.3m)/V(0.0) * Re(8.66%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for GRW ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle